-
4
pages
-
English
-
Documents
-
2014
Description
OxThera AB Receives SEK 70 MillionOxThera AB Receives SEK 70 Million Financing to Continue its Key Clinical Programs PR Newswire STOCKHOLM, April 16, 2014 OxThera AB, a privately-held Stockholm-based biopharmaceutical company, today announced that a syndicate of
-
Publié par
-
Publié le
16 avril 2014
-
Langue
English